Diligence memo · auto-generated · as of July 2, 2026

Avantis Medical Systems Inc

Avantis Medical Systems Inc looks under-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Avantis Medical Systems Inc operates in Healthtech, based in SAN JOSE.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Avantis Medical Systems Inc has raised $48M in disclosed capital across 14 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).

Largest single filing: $18M on 2011-06-24.

Most recent recorded round closed around 2018-02-28.

Valuation (modeled)modeled

Provath models Avantis Medical Systems Inc at approximately $57M (range $5.4M–$218M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.11× the median modeled value of Series B Healthtech companies in 2016–2018 (33 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 5 months.

Last raise 8.3 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round stepped up 4.3× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 90% of Healthtech peers (2138 compared).

Modeled value ranks above 65% of those peers.

Closest niche peers: Altimate Medical Holdings, Inc., Southeast Healthcare Partners II, LLC, NRS Health & Wellness GP LLC, Aspire Health, Inc., Uprising Health LLC.

Peoplefiled

24 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.